Skip to Main Content

Paper Details

Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Neurooncol Adv
3
2021
ABT-898, AKT, C-MYC, MB, MB cells, MB tumor cells, MYC, MYC-amplified human MB, MYC-associated, MYC-driven, Medulloblastoma, TSP-1, Thrombospondin-1, cell lines, group, group 3 MBs, human, medulloblastoma, murine, thrombospondin-1, tumor, xenografts
Author NameAffiliation
Tiffany ChanUniversity of Toronto
Tiffany ChanArthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children
Tiffany ChanUniversity of Toronto
Tiffany ChanArthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children
Daniel PicardUniversity of Toronto
Cynthia HawkinsArthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children
Cynthia HawkinsThe Hospital for Sick Children
Cynthia HawkinsArthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children
Cynthia HawkinsThe Hospital for Sick Children
Stefan M PfisterClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), University Hospital Heidelberg
Stefan M PfisterClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), University Hospital Heidelberg
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), University Hospital Heidelberg
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), University Hospital Heidelberg
Martine F RousselSt. Jude Children's Research Hospital
Robert J Wechsler-ReyaSanford-Burnham Medical Research Institute
Robert J Wechsler-ReyaSanford-Burnham Medical Research Institute
Eric BouffetUniversity of Toronto
Annie HuangUniversity of Toronto
Annie HuangArthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children
  • 1 - 19

Datasets